From a biochemical clinical viewpoint, Relafen 750 ( its salt form) presents a interesting case. Its mechanism of action primarily involves inhibiting cyclooxygenase enzymes , specifically COX-1 and COX-2, thereby reducing prostaglandin production . This contributes to decreased inflammation and